Family · Pharmaceutical analytical standards
Human Coagulation Factor Viia
The activated form of coagulation factor VII: in its recombinant version (eptacog alfa), authorised in Europe in 1996 and in the United States in 1999, it stops bleeding in haemophilia with inhibitors and in congenital factor VII deficiency. This family brings together other impurities.
Did you know?The first recombinant version is produced in baby hamster kidney cells; a more recent one is instead obtained from the milk of genetically modified rabbits.
No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.